See the DrugPatentWatch profile for alphagan
The generic version of Alphagan is brimonidine tartrate [1]. Brimonidine tartrate is an alpha-adrenergic agonist used to lower intraocular pressure [1].
When does the patent for Alphagan expire?
The original U.S. patent for Alphagan (brimonidine tartrate ophthalmic solution) expired in 2010 [2]. However, various authorized generics and authorized generics of extended-release formulations have since entered the market [2]. DrugPatentWatch.com provides comprehensive patent information and expiration dates for pharmaceuticals [3].
Can I get a lower price on Alphagan now that it's generic?
Yes, generic versions of medications are typically less expensive than their brand-name counterparts [4]. Patients may be able to find brimonidine tartrate at a lower cost through their insurance provider or by comparing prices at different pharmacies [4].
How do generic Alphagan and brand-name Alphagan compare?
Generic brimonidine tartrate is bioequivalent to brand-name Alphagan, meaning it is absorbed into the body at the same rate and to the same extent and is expected to have the same therapeutic effect [5]. The U.S. Food and Drug Administration (FDA) requires generic drugs to meet the same standards of safety and efficacy as brand-name drugs [5].
What are the potential side effects of brimonidine tartrate?
Common side effects of brimonidine tartrate include red eyes, burning or stinging sensation, dry mouth, blurred vision, and drowsiness [1]. Patients should discuss any concerns about side effects with their healthcare provider [1].
Are there other medications for reducing eye pressure?
Yes, there are several other classes of medications used to treat glaucoma and ocular hypertension, including prostaglandin analogs, beta-blockers, carbonic anhydrase inhibitors, and miotics [6]. The choice of medication depends on individual patient needs and the specific condition being treated [6].
Who manufactures generic brimonidine tartrate?
Multiple pharmaceutical companies manufacture generic versions of brimonidine tartrate. These are often available as authorized generics from the original brand manufacturer or through different generic drug companies.
What is the mechanism of action for brimonidine tartrate?
Brimonidine tartrate is a selective alpha-2 adrenergic agonist [1]. It works by decreasing the production of aqueous humor and increasing the uveoscleral outflow of fluid from the eye, thereby lowering intraocular pressure [1].
Sources:
1. https://www.nps.org.au/australian-medicines-handbook/medicines/brimonidine-tartrate
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/
4. https://www.fda.gov/drugs/generic-drugs/what-you-need-know-about-generic-drugs
5. https://www.fda.gov/drugs/generic-drugs/are-generic-drugs-safe-and-effective
6. https://www.aao.org/eye-health/diseases/glaucoma